HTR2B

Chr 2

5-hydroxytryptamine receptor 2B

Also known as: 5-HT(2B), 5-HT-2B, 5-HT2B

The protein encoded by this gene is a G-protein coupled receptor for serotonin that regulates neurotransmitter release, cardiovascular function, heart development, and bone density through activation of phospholipase C signaling pathways. Mutations cause autosomal recessive disorders affecting multiple systems including the heart, bones, and nervous system, with manifestations that can include cardiac abnormalities and behavioral changes. This gene is extremely intolerant to loss-of-function mutations (very low pLI and high LOEUF scores), indicating that complete loss of protein function is likely to cause significant disease.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
37
Pubs (1 yr)
28
P/LP submissions
0%
P/LP missense
1.33
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryHTR2B
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
28 unique Pathogenic / Likely Pathogenic· 64 VUS of 103 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.33LOEUF
pLI 0.000
Z-score 0.48
OE 0.88 (0.591.33)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.13Z-score
OE missense 1.02 (0.921.14)
258 obs / 252.0 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.88 (0.591.33)
00.351.4
Missense OE1.02 (0.921.14)
00.61.4
Synonymous OE1.10
01.21.6
LoF obs/exp: 16 / 18.2Missense obs/exp: 258 / 252.0Syn Z: -0.77
DN
0.7327th %ile
GOF
0.81top 10%
LOF
0.3261th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

103 submitted variants in ClinVar

Classification Summary

Pathogenic28
VUS64
Likely Benign2
Benign6
28
Pathogenic
64
VUS
2
Likely Benign
6
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
28
0
28
Likely Pathogenic
0
0
0
0
0
VUS
0
61
3
0
64
Likely Benign
0
2
0
0
2
Benign
0
4
0
2
6
Total067312100

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HTR2B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →